The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Talquetamab (Tal) therapy in relapsed/refractory (R/R) multiple myeloma (MM): Assessing weight loss and dysgeusia.
 
Syed Mujtaba Ali Naqvi
No Relationships to Disclose
 
Asis Shrestha
No Relationships to Disclose
 
Marah Alzubi
No Relationships to Disclose
 
Jawad Alrawabdeh
No Relationships to Disclose
 
Sharmilan Thanendrarajan
No Relationships to Disclose
 
Maurizio Zangari
No Relationships to Disclose
 
Frits van Rhee
Consulting or Advisory Role - Celgene; GlaxoSmithKline; Janssen Biotech; Sanofi; Takeda
 
Carolina D. Schinke
No Relationships to Disclose
 
Samer Al Hadidi
Consulting or Advisory Role - Janssen; Pfizer; Sanofi
Research Funding - Alexion Pharmaceuticals (Inst)